Grade 3/4 neutropenia is a limiting factor in second-line FOLFIRI following FOLFOX4 failure in elderly patients with metastatic colorectal cancer

Previous studies have reported improved outcomes for elderly patients with metastatic colorectal cancer (mCRC) treated with oxaliplatin or irinotecan as first-line chemotherapy. However, few studies regarding second-line chemotherapy with oxaliplatin or irinotecan are currenlty available. We analyze...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: KUBOKI, YASUTOSHI, MIZUNUMA, NOBUYUKI, OZAKA, MASATO, OGURA, MARIKO, SUENAGA, MITSUKUNI, SHINOZAKI, EIJI, MATSUSAKA, SATOSHI, CHIN, KEISHOU, MATSUURA, MASAAKI, HATAKE, KIYOHIKO
Format: Artigo
Langue:Inglês
Publié: D.A. Spandidos 2011
Sujets:
Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3410456/
https://ncbi.nlm.nih.gov/pubmed/22866109
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2011.260
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires